Evidence map›Paper›PMID 36010347›Full record

ArticleDiagnostics (Basel, Switzerland)2022

A Computational Approach to Identification of Candidate Biomarkers in High-Dimensional Molecular Data.

Justin Gerolami, Justin Jong Mun Wong, Ricky Zhang, Tong Chen, Tashifa Imtiaz, Miranda Smith, Tamara Jamaspishvili, Madhuri Koti, Janice Irene Glasgow, Parvin Mousavi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Justin GerolamiSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Justin Jong Mun WongDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0001-9931-6539
Ricky ZhangSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Tong ChenSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Tashifa ImtiazDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
Miranda SmithSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Tamara JamaspishviliDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
Madhuri KotiDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
Janice Irene GlasgowSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Parvin MousaviSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.
Neil RenwickDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0001-6695-8236
Kathrin TyryshkinSchool of Computing, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0002-7726-6654
Queen's University · CASUNY Upstate Medical University · US

Funding

Natural Sciences and Engineering Research Council 468240SEAMO AHSC Innovation Fund
6 · The paper itself

Abstract

Complex high-dimensional datasets that are challenging to analyze are frequently produced through '-omics' profiling. Typically, these datasets contain more genomic features than samples, limiting the use of multivariable statistical and machine learning-based approaches to analysis. Therefore, effective alternative approaches are urgently needed to identify features-of-interest in '-omics' data. In this study, we present the molecular feature selection tool, a novel, ensemble-based, feature selection application for identifying candidate biomarkers in '-omics' data. As proof-of-principle, we applied the molecular feature selection tool to identify a small set of immune-related genes as potential biomarkers of three prostate adenocarcinoma subtypes. Furthermore, we tested the selected genes in a model to classify the three subtypes and compared the results to models built using all genes and all differentially expressed genes. Genes identified with the molecular feature selection tool performed better than the other models in this study in all comparison metrics: accuracy, precision, recall, and F1-score using a significantly smaller set of genes. In addition, we developed a simple graphical user interface for the molecular feature selection tool, which is available for free download. This user-friendly interface is a valuable tool for the identification of potential biomarkers in gene expression datasets and is an asset for biomarker discovery studies.

Indexed as

big data analysisbiomarkerfeature selectionprostate adenocarcinomaRNA-Seq

Identifiers

PMID36010347
PMCPMC9407361
OpenAlexW4293680078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.